Contract 75D30121P12509
Georgia Tech Research Corp · Department Of Health And Human Services · August 25, 2021
Georgia Tech Research Corp was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on August 25, 2021 for $146,000 of work in biological product (except diagnostic) manufacturing. Performance is in Atlanta, GA. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 28, 2026.
Contract details
- PIID
- 75D30121P12509
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- General Science And Technology R&D Services; General Science And Technology; Basic Research
- Place of performance
- Atlanta, GA
- First action
- August 25, 2021
- Latest action
- March 28, 2026
Description
CHARACTERIZATION OF PATHOGEN-SPECIFIC ANTIBODY RESPONSES COVID-19
Modification timeline
-
March 28, 2026Mod P00004$-104.2K
-
September 10, 2024Mod P00003$0
-
July 31, 2023Mod P00002$0
-
August 16, 2022Mod P00001$0
-
August 25, 2021Base award$250.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
| Life Technologies Corporation | Department Of Health And Human Services | March 17, 2026 | $18.9K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30121P12509?
Contract 75D30121P12509 is a federal contract awarded to Georgia Tech Research Corp by Department Of Health And Human Services on August 25, 2021 for $146,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 75D30121P12509?
Georgia Tech Research Corp won contract 75D30121P12509 from Department Of Health And Human Services.
How much is contract 75D30121P12509 worth?
Contract 75D30121P12509 has obligated $146,000 to date.